This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brake, T. Articles by Lambert, P. F. Search for Related Content PubMed PubMed Citation Articles by Brake, T. Articles by Lambert, P. F.

Comparative Analysis of Cervical Cancer in Women and in a Human Papillomavirus-Transgenic Mouse Model

Identification of Minichromosome Maintenance Protein 7 as an Informative Biomarker for Human Cervical Cancer

¹ McArdle Laboratory for Cancer Research and
² Department of Obstetrics and Gynecology, University of Wisconsin Medical School, Madison, Wisconsin, and
³ Department of Radiation Oncology, John T. Vucurevich Cancer Care Institute, Rapid City, South Dakota

Human papillomaviruses (HPVs), such as HPV-16, are associated with >99% of cervical cancers in women. Two viral oncogenes, E6 and E7, are selectively expressed in these cancers. K14E6 and K14E7 transgenic mouse strains, which express the HPV16 E6 or E7 gene in stratified squamous epithelia, display many acute and long-term phenotypes indicative of the oncogenic potential of E6 and E7 including epithelial hyperplasia, abrogation of normal DNA damage responses, and spontaneous skin tumors. When treated with estrogen, these HPV-16 transgenic mice develop a progressive disease leading to cervical cancer that shows many histopathological parallels to cervical cancer in women. In this study, we evaluated the cervical lesions that arise in these transgenic mice for the expression of biomarkers induced in human cervical cancer. These analyses, which showed close parallels in the timing and pattern of expression of cyclin E and Ki-67 in the mouse cervical disease compared with that in humans, provided further validation of this HPV-16 transgenic mouse model for human cervical cancer. We then used our mouse model to identify minichromosome maintenance protein 7 (MCM7), an E2F-induced cellular DNA replication factor, as a novel biomarker for cervical cancer. In both the mouse and human disease, strong, full thickness staining for MCM7 was seen selectively in the epithelium of high-grade intraepithelial lesions and in frank cancer. The uniform staining pattern and strong signal for MCM7 suggest that MCM7 may be a highly informative biomarker for cervical cancer.

This article has been cited by other articles:

				S.-H. Chung and P. F. Lambert Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists PNAS, November 17, 2009; 106(46): 19467 - 19472. [Abstract] [Full Text] [PDF]

				J. R. Garbow, A. C. Santeford, J. R. Anderson, J. A. Engelbach, and J. M. Arbeit Magnetic Resonance Imaging Defines Cervicovaginal Anatomy, Cancer, and VEGF Trap Antiangiogenic Efficacy in Estrogen-Treated K14-HPV16 Transgenic Mice Cancer Res., October 15, 2009; 69(20): 7945 - 7952. [Abstract] [Full Text] [PDF]

				M.-K. Shin, S. Balsitis, T. Brake, and P. F. Lambert Human Papillomavirus E7 Oncoprotein Overrides the Tumor Suppressor Activity of p21Cip1 in Cervical Carcinogenesis Cancer Res., July 15, 2009; 69(14): 5656 - 5663. [Abstract] [Full Text] [PDF]

				S. F. Jabbar, L. Abrams, A. Glick, and P. F. Lambert Persistence of High-Grade Cervical Dysplasia and Cervical Cancer Requires the Continuous Expression of the Human Papillomavirus Type 16 E7 Oncogene Cancer Res., May 15, 2009; 69(10): 4407 - 4414. [Abstract] [Full Text] [PDF]

				S.-H. Chung, K. Wiedmeyer, A. Shai, K. S. Korach, and P. F. Lambert Requirement for Estrogen Receptor {alpha} in a Mouse Model for Human Papillomavirus-Associated Cervical Cancer Cancer Res., December 1, 2008; 68(23): 9928 - 9934. [Abstract] [Full Text] [PDF]

				Y.-K. Shi, Y. P. Yu, Z.-H. Zhu, Y.-C. Han, B. Ren, J. B. Nelson, and J.-H. Luo MCM7 Interacts with Androgen Receptor Am. J. Pathol., December 1, 2008; 173(6): 1758 - 1767. [Abstract] [Full Text] [PDF]

				M. L. Yeung, J.-i. Yasunaga, Y. Bennasser, N. Dusetti, D. Harris, N. Ahmad, M. Matsuoka, and K.-T. Jeang Roles for MicroRNAs, miR-93 and miR-130b, and Tumor Protein 53-Induced Nuclear Protein 1 Tumor Suppressor in Cell Growth Dysregulation by Human T-Cell Lymphotrophic Virus 1 Cancer Res., November 1, 2008; 68(21): 8976 - 8985. [Abstract] [Full Text] [PDF]

				A. Shai, H. C. Pitot, and P. F. Lambert p53 Loss Synergizes with Estrogen and Papillomaviral Oncogenes to Induce Cervical and Breast Cancers Cancer Res., April 15, 2008; 68(8): 2622 - 2631. [Abstract] [Full Text] [PDF]

				K. Strati and P. F. Lambert Role of Rb-Dependent and Rb-Independent Functions of Papillomavirus E7 Oncogene in Head and Neck Cancer Cancer Res., December 15, 2007; 67(24): 11585 - 11593. [Abstract] [Full Text] [PDF]

				D. Pyeon, M. A. Newton, P. F. Lambert, J. A. den Boon, S. Sengupta, C. J. Marsit, C. D. Woodworth, J. P. Connor, T. H. Haugen, E. M. Smith, et al. Fundamental Differences in Cell Cycle Deregulation in Human Papillomavirus-Positive and Human Papillomavirus-Negative Head/Neck and Cervical Cancers Cancer Res., May 15, 2007; 67(10): 4605 - 4619. [Abstract] [Full Text] [PDF]

				A. Shai, T. Brake, C. Somoza, and P. F. Lambert The Human Papillomavirus E6 Oncogene Dysregulates the Cell Cycle and Contributes to Cervical Carcinogenesis through Two Independent Activities Cancer Res., February 15, 2007; 67(4): 1626 - 1635. [Abstract] [Full Text] [PDF]

				M. Steinau, M. S. Rajeevan, D. R. Lee, M. T. Ruffin, I. R. Horowitz, L. C. Flowers, T. Tadros, G. Birdsong, M. Husain, D. C. Kmak, et al. Evaluation of RNA Markers for Early Detection of Cervical Neoplasia in Exfoliated Cervical Cells Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 295 - 301. [Abstract] [Full Text] [PDF]

				S. Balsitis, F. Dick, N. Dyson, and P. F. Lambert Critical Roles for Non-pRb Targets of Human Papillomavirus Type 16 E7 in Cervical Carcinogenesis Cancer Res., October 1, 2006; 66(19): 9393 - 9400. [Abstract] [Full Text] [PDF]

				K. Strati, H. C. Pitot, and P. F. Lambert Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model PNAS, September 19, 2006; 103(38): 14152 - 14157. [Abstract] [Full Text] [PDF]

				M. C. Louie, A. S. Revenko, J. X. Zou, J. Yao, and H.-W. Chen Direct Control of Cell Cycle Gene Expression by Proto-Oncogene Product ACTR, and Its Autoregulation Underlies Its Transforming Activity Mol. Cell. Biol., May 15, 2006; 26(10): 3810 - 3823. [Abstract] [Full Text] [PDF]